Rating History for Lisata Therapeutics, Inc (LSTA) by Brookline Capital Markets
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 7/27/2026 | Kemp Dolliver | Downgrade | Hold (Buy) |
N/A (N/A) |
1.67 (1.65) |
-1.2% | Details |
 |
|||||||
|
|||||||
